— VC invested surges while deal volume continues decline
— Median deal sizes grow especially Series D and beyond
— Downward pressure on early rounds remains
— Mega-deal rounds return particularly in Asia
— Continued interest in biotech and autotech
— VC investment value bounces back, volume remains steady
— Series D+ median valuation hits $250 million
— US investment strong but Canada and Latin America struggle
— US VC invested reaches 2
nd
highest total since 2010
— First time financings remain stable
— M&A dominates exits but IPO’s perk up
— Richly valued late-stagers go public
— VC deal value stable, volume down
— early-stage deals continue decline
— Corporate VC participation above 20 percent
— Improbable raise of $500 million one of largest in Europe — ever
— Deal value spikes to 3
rd
highest level of decade
— Mid and late-stage deals gain traction
— Corporate VC surges to new high of 22.5 percent
— Mega-rounds return with a bang